Trial Profile
Efficacy and safety of liraglutide for perioperative blood glucose control in diabetic subjects within enhanced recovery after surgery (ERAS) protocols
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2020
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Mar 2020 Status changed from active, no longer recruiting to completed.
- 01 Feb 2018 New trial record